Patents by Inventor Tsung-Yun Liu

Tsung-Yun Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol
    Patent number: 8183297
    Abstract: The invention relates to a device for selecting stem cells with a serum free medium for amplification of stem cells. The invention also relates to a method of treating or preventing diseases caused by cancer-related stem cells. The invention further provides a method of enhancing radiosensitivity of cancer-related stem cells comprising radiotherapy with resveratrol, and the cancer-related stem cell has stronger drug resistance. The present invention further provides that resveratrol promotes differentiation and inhibits teratoma/tumor formation in induced pluripotent stem cells (iPS) and embryonic stem cells.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: May 22, 2012
    Assignee: Taipei Veterans General Hospital
    Inventors: Shih-Hwa Chiou, Tsung-Yun Liu, Tung-Hu Tsai, Jeng-Fan Lo, Yi-Ping Yang, Fu-Ting Tsai, Yu-Chih Chen, Chian-Shiu Chien
  • MEDIUM AND DEVICE FOR PROLIFERATION OF STEM CELLS AND TREATMENT OF CANCER-RELATED STEM CELL WITH RESVERATROL
    Publication number: 20100010099
    Abstract: The invention relates to a device for selecting stem cells with a serum free medium for amplification of stem cells. The invention also relates to a method of treating or preventing diseases caused by cancer-related stem cells. The invention further provides a method of enhancing radiosensitivity of cancer-related stem cells comprising radiotherapy with resveratrol, and the cancer-related stem cell has stronger drug resistance.
    Type: Application
    Filed: July 10, 2009
    Publication date: January 14, 2010
    Applicant: TAIPEI VETERANS GENERAL HOSPITAL
    Inventors: SHIH-HWA CHIOU, TSUNG-YUN LIU, TUNG-HU TSAI, JENG-FAN LO, YI-PING YANG, FU-TING TSAI, YU-CHIH CHEN, CHIAN-SHIU CHIEN
  • Use of Docetaxel for Treating Hepatocellular Carcinoma
    Publication number: 20080045584
    Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 ?M. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
    Type: Application
    Filed: June 12, 2007
    Publication date: February 21, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Chin-Wen CHI, Heng-Liang LIN, Tsung-Yun LIU, Wing-Yiu LUI, Gar-Yang CHAU
  • Use of docetaxel for treating hepatoma
    Publication number: 20030158249
    Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 &mgr;M. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
    Type: Application
    Filed: February 27, 2002
    Publication date: August 21, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Chin-Wen Chi, Heng-Liang Lin, Tsung-Yun Liu, Wing-Yiu Lui, Gar-Yang Chau